Warren Foust's most recent trade in Staar Surgical Co. was a trade of 14,662 Common Stock done . Disclosure was reported to the exchange on May 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 14,662 | 81,579 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2026 | 14,662 | 14,662 | - | - | Performance Stock Units | |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. | 15 May 2026 | 7,460 | 74,119 (0%) | 0% | 32.1 | 239,242 | Common Stock |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 7,331 | 81,450 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 7,331 | 85,051 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2026 | 7,331 | 21,993 | - | - | Performance Stock Units | |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2026 | 7,331 | 29,324 | - | - | Performance Stock Units | |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. | 15 May 2026 | 3,730 | 77,720 (0%) | 0% | 32.1 | 119,621 | Common Stock |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. | 15 May 2026 | 3,730 | 81,321 (0%) | 0% | 32.1 | 119,621 | Common Stock |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 3,666 | 84,987 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2026 | 3,666 | 32,990 | - | - | Performance Stock Units | |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. | 15 May 2026 | 1,865 | 83,112 (0%) | 0% | 32.1 | 59,811 | Common Stock |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.69 per share. | 08 May 2026 | 3,448 | 66,917 (0%) | 0% | 26.7 | 92,027 | Common Stock |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2026 | 45,117 | 45,117 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 19,550 | 53,813 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 19,550 | 39,101 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 9,775 | 63,588 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 9,775 | 19,551 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 8,175 | 8,175 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 8,175 | 34,263 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Warren Foust | Interim Co-CEO and Pres. & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 20,787 | 20,787 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Warren Foust | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 58,651 | 58,651 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Warren Foust | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 29,326 | 29,326 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Warren Foust | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 8,175 | 16,350 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Warren Foust | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 8,175 | 26,088 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Warren Foust | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.02 per share. | 08 May 2024 | 2,418 | 17,913 (0%) | 0% | 41.0 | 99,186 | Common Stock |
| Staar Surgical Co. | Warren Foust | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 24,525 | 24,525 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Warren Foust | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 21,966 | 21,996 | - | - | Common Stock Options | |
| Staar Surgical Co. | Warren Foust | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 37,567 | 37,567 | - | - | Common Stock Options | |
| Staar Surgical Co. | Warren Foust | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 20,331 | 20,331 (0%) | 0% | 0 | Common Stock |